Sunday, May 18, 2025
5/18/2025
Selective Methods to Transform Pyridines and Diazines that Facilitate Medicinal Chemistry - Project Abstract. The goal of this project is to introduce new synthetic strategiesto functionalize pyridine and diazine heterocycles. Pyridines are the second most common nitrogen heterocycle found in FDA approved drugs, and there are numerous examples of diazines in these structures. The widespread occurrence arises because of a combined effect of the heterocycle and its substituents. The key drug-receptor interaction is often comprised of a hydrogen bond between the heterocycles N-lone pairs and the biological target. These heterocycles are also polar, can engage in p-stacking interactions and are resistant to oxidative metabolism. The substituents enable tuning of the steric and electronic environment of the heterocycle as well as serving as additional binding sites. As such, medicinal chemists require chemical process that can directly and selectively install a range of substituents at various stages of drug discovery from C–H precursors. In this proposal we will develop three different approaches for azine functionalization. First, we will install heterocyclic phosphonium salts and exploit their unique reactivity to develop coupling reactions with amines, thiophenols, cysteine containing molecules and alkynes. Using phosphines with pendant functional groups will enable coupling with water and ammonia. Second, direct coupling reactions between NTf-pyridinium salts and nucleophiles will be exploited for C–Heteroatom bond formation. Additionally, this platform will enable direct coupling with aliphatic amines, anilines, amides and sulfonamides. Third, we will use a new version of Zincke ring-opening chemistry to enable 3-selective pyridine functionalization reactions via reaction that form C–C and C–Heteroatom bonds. We will also use this Zincke platform to isotopically exchange 14N pyridines to 15N pyridines as well as incorporating deuterium atoms at the 3-, and 5- positions to create higher mass isotopologs that are required for drug toxicology studies. Forth, we will use a deconstruction-reconstruction approach to transform heterocycles such as pyrimidines into their substituted variants, and also to other distinct heterocycles such as 1,2-oxazoles, pyrazoles and pyridines. This approach will also enable us to access higher mass pyrimidine isotopologs.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).